Medifast provided earnings guidance for the first quarter of 2024. For the period, the company expects revenue to be in the range of $155 million to $175 million and diluted EPS to be in the range of $0.25 to $0.95.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.94 USD | +2.28% |
|
-3.04% | -70.34% |
06-24 | Medifast, Inc.(NYSE:MED) dropped from S&P 600 Consumer Staples | CI |
06-24 | Medifast, Inc.(NYSE:MED) dropped from S&P 1000 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-70.34% | 208M | |
+15.27% | 8.44B | |
+3.45% | 7.56B | |
-11.26% | 5.04B | |
-7.65% | 3.7B | |
-18.20% | 3.24B | |
-11.27% | 1.23B | |
-29.91% | 1.08B | |
-10.12% | 850M | |
-16.62% | 849M |
- Stock Market
- Equities
- MED Stock
- News Medifast, Inc.
- Medifast Provides Earnings Guidance for the First Quarter of 2024